Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Human Albumin for Hypoalbuminemia in Cirrhotic Patients with Ascites
NCT06911554Phase 3Completed
- Sponsor
- Tonghua Anrate Biopharmaceutical Co., Ltd.
- Start
- Jun 2023
- Primary completion
- Sep 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant human albumin in hypoalbuminemia, sponsored by Tonghua Anrate Biopharmaceutical Co., Ltd.. Started Jun 2023; status: completed.
02
Drugs
recombinant human albumin
03
Conditions
hypoalbuminemia
Beyond the preview
Go deeper on NCT06911554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06911554.